TickerFacts.

RenovoRx, Inc. (RNXT): Revenue

Annual figures by period end, from SEC filings.

$1.12M
Year ended 2025-12-31
$1.98M
Trailing 12 months to 2026-06-30
2024-12-31: $43.0K2025-12-31: $1.12M$1.12M
2024-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$1.12Mn/m2026-03-30, From 2025-01-01
2024-12-31$43.0Kn/a2026-03-30, From 2024-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
RenovoRx, Inc. (RNXT)2025-12-31$1.12Mn/m
PetVivo Holdings, Inc. (PETV)2026-03-31$1.14M+0.8%
SeaStar Medical Holding Corp (ICU)2025-12-31$1.23M+814.1%
Sintx Technologies, Inc. (SINT)2025-12-31$1.02M-64.7%
Flyte Aviation, Inc. (VJET)2025-12-31$819.0K+95.0%
EBR Systems, Inc. (NONE.)2025-12-31$1.62Mn/a
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31$704.0K+63.7%
Vycor Medical Inc (VYCO)2025-12-31$1.86M+17.2%
Co-Diagnostics, Inc. (CODX)2025-12-31$622.5K-84.1%

Compare RNXT, PETV, ICU, SINT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗